Company Appoints Former Novartis Norway CEO as President of European Operations, and Partners with Dr. David Erritzoe in the set up of a novel collaborative psychopharmacology/psychedelic research clinic between Imperial College London and a major mental health NHS Trust in London DENVER, March 16, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine”…


Previous articleDC’s Initiative 81 Becomes Law: Effectively Decriminalizes Entheogenic Plants and Fungi
Next articlePT235 – The Entheo Society of Washington – Dismantling Power Systems Through Decriminalization